Nikolai Kley is the founder of Orionis Biosciences. Orionis Biosciences has raised $85M in total funding. Latest round: Series C.
Nikolai Kley is the Founder, President, and CEO of Orionis Biosciences, a life sciences company focused on developing selective therapeutics for cancer. He has led the company since its inception in January 2015, advancing it into clinical trials and securing over $85 million in total funding.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide